Liquid Embolic Agents for Endovascular Embolization: Evaluation of an Established (Onyx) and a Novel (PHIL) Embolic Agent in an In Vitro AVM Model

References

1. 1.↵
   2. Friedlander RM

   . Clinical practice. Arteriovenous malformations of the brain. N Engl J Med 2007;356:2704–12 doi:10.1056/NEJMcp067192 pmid:17596605

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Pierot L,
   3. Cognard C,
   4. Herbreteau D, et al

   . Endovascular treatment of brain arteriovenous malformations using a liquid embolic agent: results of a prospective, multicentre study (BRAVO). Eur Radiol 2013;23:2838–45 doi:10.1007/s00330-013-2870-6 pmid:23652849

   CrossRefPubMed
3. 3.↵
   2. van Rooij WJ,
   3. Sluzewski M,
   4. Beute GN

   . Brain AVM embolization with Onyx. AJNR Am J Neuroradiol 2007;28:172–77; discussion 178 pmid:17213451

   Abstract/FREE Full Text
4. 4.↵
   2. Gross BA,
   3. Du R

   . Diagnosis and treatment of vascular malformations of the brain. Curr Treat Options Neurol 2014;16:279 doi:10.1007/s11940-013-0279-9 pmid:24318447

   CrossRefPubMed
5. 5.↵
   2. Taki W,
   3. Yonekawa Y,
   4. Iwata H, et al

   . A new liquid material for embolization of arteriovenous malformations. AJNR Am J Neuroradiol 1990;11:163–68 pmid:2105599

   Abstract/FREE Full Text
6. 6.↵
   2. Bruno CA Jr.,
   3. Meyers PM

   . Endovascular management of arteriovenous malformations of the brain. Interv Neurol 2013;1:109–23 doi:10.1159/000346927 pmid:25187772

   CrossRefPubMed
7. 7.↵
   2. Hu YC,
   3. Newman CB,
   4. Dashti SR, et al

   . Cranial dural arteriovenous fistula: transarterial Onyx embolization experience and technical nuances. J Neurointerv Surg 2011;3:5–13 doi:10.1136/jnis.2010.003707 pmid:21990779

   Abstract/FREE Full Text
8. 8.↵
   2. Elsenousi A,
   3. Aletich VA,
   4. Alaraj A

   . Neurological outcomes and cure rates of embolization of brain arteriovenous malformations with n-butyl cyanoacrylate or Onyx: a meta-analysis. J Neurointerv Surg 2016;8:265–72 doi:10.1136/neurintsurg-2014-011427 pmid:25540177

   Abstract/FREE Full Text
9. 9.↵
   2. Ayad M,
   3. Eskioglu E,
   4. Mericle RA

   . Onyx: a unique neuroembolic agent. Expert Rev Med Devices 2006;3:705–15 doi:10.1586/17434440.3.6.705 pmid:17280535

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Kocer N,
    3. Hanımoğlu H,
    4. Batur Ş, et al

    . Preliminary experience with precipitating hydrophobic injectable liquid in brain arteriovenous malformations. Diagn Interv Radiol 2016;22:184–89 doi:10.5152/dir.2015.15283 pmid:26782157

    CrossRefPubMed
11. 11.↵
    2. Samaniego EA,
    3. Kalousek V,
    4. Abdo G, et al

    . Preliminary experience with Precipitating Hydrophobic Injectable Liquid (PHIL) in treating cerebral AVMs. J Neurointerv Surg 2016 Jan 27. [Epub ahead of print] doi:10.1136/neurintsurg-2015-012210 pmid:26819446

    CrossRefPubMed
12. 12.↵
    2. Leyon JJ,
    3. Chavda S,
    4. Thomas A, et al

    . Preliminary experience with the liquid embolic material agent PHIL (precipitating hydrophobic injectable liquid) in treating cranial and spinal dural arteriovenous fistulas: technical note. J Neurointerv Surg 2016;8:596–602 doi:10.1136/neurintsurg-2015-011684 pmid:25994938

    Abstract/FREE Full Text
13. 13.↵
    2. Ishikawa M,
    3. Horikawa M,
    4. Yamagami T, et al

    . Embolization of arteriovenous malformations: effect of flow control and composition of n-butyl-2 cyanoacrylate and iodized oil mixtures with and without ethanol in an in vitro model. Radiology 2016;279:910–16 doi:10.1148/radiol.2015142583 pmid:26690906

    CrossRefPubMed
14. 14.↵
    2. Inagawa S,
    3. Isoda H,
    4. Kougo H, et al

    . In-vitro simulation of NBCA embolization for arteriovenous malformation. Interv Neuroradiol 2003;9:351–58 doi:10.1177/159101990300900404 pmid:20591314

    CrossRefPubMed
15. 15.↵
    2. Chang W,
    3. Loecher MW,
    4. Wu Y, et al

    . Hemodynamic changes in patients with arteriovenous malformations assessed using high-resolution 3D radial phase-contrast MR angiography. AJNR Am J Neuroradiol 2012;33:1565–72 doi:10.3174/ajnr.A3010 pmid:22499844

    Abstract/FREE Full Text
16. 16.↵
    2. Nornes H,
    3. Grip A

    . Hemodynamic aspects of cerebral arteriovenous malformations. J Neurosurg 1980;53:456–64 doi:10.3171/jns.1980.53.4.0456 pmid:7420165

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Rossitti S

    . Pathophysiology of increased cerebrospinal fluid pressure associated to brain arteriovenous malformations: the hydraulic hypothesis. Surg Neurol Int 2013;4:42 doi:10.4103/2152-7806.109657 pmid:23607064

    CrossRefPubMed
18. 18.↵
    2. Frontera JA,
    3. Moatti J,
    4. de los Reyes KM, et al

    . Safety and cost of stent-assisted coiling of unruptured intracranial aneurysms compared with coiling or clipping. J Neurointerv Surg 2014;6:65–71 doi:10.1136/neurintsurg-2012-010544 pmid:23223396

    Abstract/FREE Full Text